ClearPoint Neuro Reports Third-Quarter 2026 Results
Revenue rose 36% to $12.1 million from $8.9 million a year earlier. Net loss widened to $7.5 million from $5.9 million, and diluted loss per share was $(0.24) versus $(0.21).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.